Ethyl 2-carbamoyloxybenzoate
CAS No. 88599-32-0
Ethyl 2-carbamoyloxybenzoate( —— )
Catalog No. M28404 CAS No. 88599-32-0
Ethyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 48 | Get Quote |
|
| 5MG | 74 | Get Quote |
|
| 10MG | 111 | Get Quote |
|
| 25MG | 188 | Get Quote |
|
| 50MG | 284 | Get Quote |
|
| 100MG | 426 | Get Quote |
|
| 500MG | 972 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEthyl 2-carbamoyloxybenzoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.
-
DescriptionEthyl 2-carbamoyloxybenzoate is a compound used as a molecular building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88599-32-0
-
Formula Weight209.201
-
Molecular FormulaC10H11NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)c1ccccc1OC(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liang L, Wang X, Sun Y, Ma P, Li X, Piao H, Jiang Y, Song D. Magnetic solid-phase extraction of triazine herbicides from rice using metal-organic framework MIL-101(Cr) functionalized magnetic particles. Talanta. 2018 Mar 1;179:512-519. doi: 10.1016/j.talanta.2017.11.017. Epub 2017 Nov 28. PubMed PMID: 29310269.
molnova catalog
related products
-
FL118
FL118 is a novel survivin inhibitor that inhibits cancer stem cell-like properties.FL118 is a novel camptothecin analog with anticancer activity that inhibits epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway, thereby inhibiting migration and invasion of human breast cancer cells.
-
Adibendan
Adibendan is a phosphodiesterase III inhibitor.
-
SynuClean-D
SynuClean-D is an α-synuclein aggregation inhibitor preventing fibril propagation, disrupting mature amyloid fibrils, and abolishing the degeneration of dopaminergic neurons in an animal model of Parkinson’s disease.
Cart
sales@molnova.com